hypericin has been researched along with Angiogenesis, Pathologic in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In conclusion, NTRT improved the anticancer efficacy of VDT in rabbits with VX2 tumors." | 5.42 | Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models. ( Chen, F; Dai, X; Li, Y; Ni, Y; Shao, H; Sun, Z; Xu, K; Zhang, J, 2015) |
| "Photodynamic therapy with hypericin (HY-PDT) and hyperforin (HP) could be treatment modalities for colorectal cancer (CRC), but evidence of their effect on angiogenic factors in CRC is missing." | 3.91 | Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane. ( Babinčák, M; Buríková, M; Fedoročko, P; Jendželovská, Z; Jendželovský, R; Košuth, J; Majerník, M; Ševc, J; Tonelli Gombalová, Z, 2019) |
| "Hypericin is a naturally occurring secondary metabolite in plants of the Hypericum genus, with Hypericum perforatum (St." | 2.43 | Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. ( Kiesslich, T; Krammer, B; Plaetzer, K, 2006) |
| "In conclusion, NTRT improved the anticancer efficacy of VDT in rabbits with VX2 tumors." | 1.42 | Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models. ( Chen, F; Dai, X; Li, Y; Ni, Y; Shao, H; Sun, Z; Xu, K; Zhang, J, 2015) |
| " However, the tumors administered with a initial dose of CX at 24-h post-PDT had no tumor control." | 1.33 | Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. ( Olivo, M; Soo, KC; Yee, KK, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majerník, M | 1 |
| Jendželovský, R | 1 |
| Babinčák, M | 1 |
| Košuth, J | 1 |
| Ševc, J | 1 |
| Tonelli Gombalová, Z | 1 |
| Jendželovská, Z | 1 |
| Buríková, M | 1 |
| Fedoročko, P | 1 |
| Shao, H | 1 |
| Zhang, J | 1 |
| Sun, Z | 1 |
| Chen, F | 1 |
| Dai, X | 1 |
| Li, Y | 1 |
| Ni, Y | 2 |
| Xu, K | 1 |
| Bhuvaneswari, R | 2 |
| Gan, YY | 1 |
| Lucky, SS | 1 |
| Chin, WW | 1 |
| Ali, SM | 1 |
| Soo, KC | 2 |
| Olivo, M | 3 |
| Stupáková, V | 1 |
| Varinská, L | 1 |
| Mirossay, A | 1 |
| Sarisský, M | 1 |
| Mojzis, J | 1 |
| Dankovcík, R | 1 |
| Urdzík, P | 1 |
| Ostró, A | 1 |
| Mirossay, L | 1 |
| Marysael, T | 1 |
| Lerut, E | 1 |
| de Witte, P | 2 |
| Yuen, GY | 1 |
| Chee, SK | 1 |
| Hendrickx, N | 1 |
| Dewaele, M | 1 |
| Buytaert, E | 1 |
| Marsboom, G | 1 |
| Janssens, S | 1 |
| Van Boven, M | 1 |
| Vandenheede, JR | 1 |
| Agostinis, P | 1 |
| Yee, KK | 1 |
| Kiesslich, T | 1 |
| Krammer, B | 1 |
| Plaetzer, K | 1 |
1 review available for hypericin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Humans; Hydrogen-Io | 2006 |
8 other studies available for hypericin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
Topics: Angiogenesis Inducing Agents; Animals; Anthracenes; Biomarkers; Cell Line, Tumor; Chick Embryo; Chor | 2019 |
Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.
Topics: Animals; Anthracenes; Autoradiography; Disease Models, Animal; Iodine Radioisotopes; Necrosis; Neopl | 2015 |
Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
Topics: Angiogenic Proteins; Animals; Anthracenes; Blotting, Western; Cell Line, Tumor; Endoscopy; Fluoresce | 2008 |
Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines.
Topics: Anthracenes; Cell Line, Tumor; Cell Movement; DNA Fragmentation; Endothelial Cells; Gelatinases; Hum | 2009 |
Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors.
Topics: Animals; Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Mice; Mice, Inbred C3H; Necrosis; Neo | 2011 |
Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2011 |
Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy.
Topics: Anthracenes; Cell Line; Cell Movement; Drug Delivery Systems; Endothelial Cells; Enzyme Inhibitors; | 2005 |
Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Celecoxib; Cyclooxygenase 2; Drug Therapy, Combinatio | 2005 |